| Literature DB >> 19542468 |
Kirk A Staschke1, Sucai Dong, Joy Saha, Jingyong Zhao, Nathan A Brooks, Deena L Hepburn, Jinqi Xia, Muhammet F Gulen, Zizhen Kang, Cengiz Z Altuntas, Vincent K Tuohy, Raymond Gilmour, Xiaoxia Li, Songqing Na.
Abstract
Both IL-23- and IL-1-mediated signaling pathways play important roles in Th17 cell differentiation, cytokine production, and autoimmune diseases. The IL-1R-associated kinase 4 (IRAK4) is critical for IL-1/TLR signaling. We show here that inactivation of IRAK4 kinase in mice (IRAK4 KI) results in significant resistance to experimental autoimmune encephalomyelitis due to a reduction in infiltrating inflammatory cells into the CNS and reduced Ag-specific CD4(+) T cell-mediated IL-17 production. Adoptive transfer of myelin oligodendrocyte glycoprotein 35-55-specific IRAK4 KI Th17 cells failed to induce experimental autoimmune encephalomyelitis in either wild-type or IRAK4 KI recipient mice, indicating the lack of autoantigen-specific Th17 cell activities in the absence of IRAK4 kinase activity. Furthermore, the absence of IRAK4 kinase activity blocked induction of IL-23R expression, STAT3 activation by IL-23, and Th17 cytokine expression in differentiated Th17 cells. Importantly, blockade of IL-1 signaling by IL-1RA inhibited Th17 differentiation and IL-23-induced cytokine expression in differentiated Th17 cells. The results of these studies demonstrate that IL-1-mediated IRAK4 kinase activity in T cells is essential for induction of IL-23R expression, Th17 differentiation, and autoimmune disease.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19542468 PMCID: PMC3638260 DOI: 10.4049/jimmunol.0802361
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422